<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>356ba8fb-b816-4437-842e-17a5c19904fb</id>
  <name>Postoperative Analgesics and Antipyretics Smart Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~356ba8fb-b816-4437-842e-17a5c19904fb~NAME~Postoperative Analgesics and Antipyretics Smart Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Consider non-opioid analgesia or appropriate opioid-sparing multimodal analgesia. If needed, short acting opioids are recommended. Long acting opioids should be avoided. Consider dose reduction if patient is elderly.&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetaminophen Tablet; 975 to 1000 mg, PO every 6 hours x 5 days or until discharge. On Unit #1&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Maximum of 4000 mg acetaminophen in 24 hours from all sources&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #1&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Choose for elderly:&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetaminophen Tablet; 500 to 650 mg, PO every 6 hours x 7 days  On Unit&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Maximum of 4000 mg acetaminophen in 24 hours from all sources&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #2&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;strong&gt;NSAIDs&lt;/strong&gt; &lt;em&gt;should be used with caution in patients:&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;? with renal impairment or high risk of acute kidney injury&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;? with history of GI bleed or peptic ulcers&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;? with history of intracranial bleed or high risk of bleeding (such as anticoagulation therapy)&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;? with history of myocardial infarction, cardiovascular disease, or congestive heart failure (CHF)&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #3&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Choose for elderly:&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #4&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Use caution if patient has renal impairment or is at high risk of acute kidney injury. If patient has indwelling epidural choose celecoxib: &lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #6&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;Choose for elderly: &lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #5&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;For pain not controlled by non-opioid analgesia. Consider dose reduction if patient is elderly or opiate-naïve.&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #7&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;em&gt;For pain not controlled by oral opioids, or oral analgesia is contraindicated. Consider dose reduction if patient is elderly or opiate-naïve. Choose same oral and parenteral opioid agent.&lt;/em&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Postoperative Analgesics and Antipyretics">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen Tablet Order" max="1" path="/items" name="acetaminophen Tablet; 975 to 1000 mg, PO every 6 hours x 5 days or until discharge. On Unit #1"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen Tablet Order" max="1" path="/items" name="acetaminophen Tablet; 500 to 650 mg, PO every 6 hours x 7 days  On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #2"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen Tablet Order" max="1" path="/items" name="ibuprofen Tablet; 400 mg, PO Q6h x  3 days or until discharge On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #3"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen Tablet Order" max="1" path="/items" name="ibuprofen Tablet; 200 mg, PO Q6h x 3 days or until discharge On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #4"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="495d0d90-a746-40af-badb-6f8e715c5371" concept_name="PHARM celecoxib Capsule Order" max="1" path="/items" name="celecoxib Capsule; 200 mg PO bid x 3 days or until discharge, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #6"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="495d0d90-a746-40af-badb-6f8e715c5371" concept_name="PHARM celecoxib Capsule Order" max="1" path="/items" name="celecoxib Capsule; 100 mg PO bid x 3 days or until discharge, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="OR"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="856e1810-6754-4158-9a74-811d23b3b39c" concept_name="PHARM ketorolac injection Order" max="1" path="/items" name="ketorolac Injection; 10 mg IV  q8h x 2 days or until discharge, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Opioids Oral (single response)"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #5"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="0f57fb7d-059a-4be4-9290-b8398ab42fc8" concept_name="PHARM morphine, short acting Tablet Order" max="1" path="/items" name="morphine, short acting Tablet; 5-10mg PO Q4h PRN for pain not controlled by non-opioid analgesia, On Unit"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="50b56831-0738-4764-9120-bee1ec804fc8" concept_name="PHARM HYDROmorphone, short acting Tablet Order" max="1" path="/items" name="HYDROmorphone, short acting Tablet; 1-2mg Q4h PRN for pain not controlled by non-opioid analgesia, On Unit"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="760cbafb-ca4e-4322-a162-d0d22644cf19" concept_name="PHARM oxyCODONE, short acting Tablet Order" max="1" path="/items" name="oxyCODONE, short acting Tablet; 5 mg Q4h PRN for pain not controlled by non-opioid analgesia, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Opioids IV (single response)"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #7"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="67565029-6e61-4591-8677-1c12a114619d" concept_name="PHARM morphine injection Order" max="1" path="/items" name="morphine Injection; 2.5-5mg Q4h PRN for pain not controlled by oral opioids, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="67565029-6e61-4591-8677-1c12a114619d" concept_name="PHARM morphine injection Order" max="1" path="/items" name="morphine Injection; 1 - 2  mg, SUBCUT every 4 hours PRN for pain not controlled by oral opioids, On Unit"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f914227a-56ca-439c-adea-97c092940687" concept_name="PHARM HYDROmorphone infusion (adult) Order" max="1" path="/items" name="HYDROmorphone infusion (adult);  0.5-1mg Q4h PRN for pain not controlled by oral opioids, On Unit"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f914227a-56ca-439c-adea-97c092940687" concept_name="PHARM HYDROmorphone infusion (adult) Order" max="1" path="/items" name="HYDROmorphone infusion (adult); 0.25 to 0.5  mg, SUBCUT every 4 hours PRN for pain not controlled by oral opioids, On Unit"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
</template>